- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03211637
Wounds Protocol at Family Health Strategy Units in a Rio Grande do Sul Countryside Town
October 27, 2018 updated by: Daniel Demétrio Faustino da Silva, Hospital Nossa Senhora da Conceicao
Implementing and Assessing an Wounds Protocol at Family Health Strategy Units in a Rio Grande do Sul Countryside Town
Evaluate the process for implementing a wound protocol for lesion control and cost-effectiveness in the context of the Family Health Strategy in the city of Santa Cruz do Sul, Brazil.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Presenting vascular (venous, arterial or mixed) ulcers for over 1 year;
- Be available to have wounds dressed at the healthcare unit;
- Be a patient registered with the Family Health Strategy teams.
Exclusion Criteria:
- Have some condition rendering the patient unable to go to the unit, such as being bedridden or having had a lower limb amputated;
- Having decompensated diabetes mellitus;
- Having move away from the Family Health Strategy unit's coverage area.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: INTERVENTION GROUP
This group comprises 6 healthcare units equipped with a Family Health Strategy, where patients are seen by coordinating nurses who have been trained to use wound dressing supplies and also on the use of the protocol.
|
Nurses who have been trained to use wound dressing supplies and also on the use of the protocol.
|
Active Comparator: CONTROL GROUP
This group comprising 5 healthcare units equipped with a Family Health Strategy.
Patients were seen by coordinating nurses who used techniques and supplies with which they were already familiar.
They had no protocol in place.
|
Nurses who have been trained to use wound dressing supplies and also on the use of the protocol.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lesion remission by measuring the surface area of the wound
Time Frame: one month
|
Remission of the wound, and other clinical variables such as odor, pain, infection and presence of exudate.
|
one month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2016
Primary Completion (Actual)
December 1, 2016
Study Completion (Actual)
June 1, 2018
Study Registration Dates
First Submitted
February 27, 2017
First Submitted That Met QC Criteria
July 5, 2017
First Posted (Actual)
July 7, 2017
Study Record Updates
Last Update Posted (Actual)
October 30, 2018
Last Update Submitted That Met QC Criteria
October 27, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HNSConceicaoMP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Vascular Wounds in Adults
-
American Regent, Inc.Not yet recruiting
-
Assiut UniversityRecruitingVocal Nodules in AdultsEgypt
-
Beckley Psytech LimitedCompletedPharmacokinetics in Healthy AdultsUnited Kingdom
-
Orion Corporation, Orion PharmaCompletedContinuous Sedation in Initially Sedated Adults in ICUFinland, United Kingdom, Belgium, Germany, Netherlands, Russian Federation, Switzerland
-
Orion Corporation, Orion PharmaCompletedContinuous Sedation in Initially Sedated Adults in ICUNetherlands, Belgium, Estonia, Finland, France, Germany, Norway, Switzerland, United Kingdom
-
Beckley Psytech LimitedCompletedPharmacokinetics in Healthy AdultsUnited Kingdom
-
scPharmaceuticals, Inc.CompletedPharmacokinetics in Healthy Adults
-
University of Alabama at BirminghamCompletedPhysical Fitness in Older AdultsUnited States
-
University of ZurichCompletedMotivation in Healthy Older AdultsSwitzerland
-
Stony Brook UniversityMartinos Center for Biomedical ImagingCompleted
Clinical Trials on Wounds Protocol
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...TerminatedBurns | Wound HealingUnited States
-
E.BadiavasUnited States Department of DefenseCompleted
-
Instituto Venezolano de Investigaciones CientificasHospital Central Dr. Plácido D. Rodriguez Rivero, San Felipe, Yaracuy; Unidad... and other collaboratorsEnrolling by invitation
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingMalignant Fungating WoundChina
-
Fundacion para la Formacion e Investigacion Sanitarias...Completed
-
University of California, DavisActive, not recruiting
-
Abeona Therapeutics, IncRecruitingEpidermolysis Bullosa | Recessive Dystrophic Epidermolysis Bullosa | RDEBUnited States
-
West Virginia UniversityTerminatedSurgical WoundUnited States
-
Samsun Liv HospitalCompletedWound Healing Delayed
-
Next Science TMUniversity of Maryland, BaltimoreWithdrawnSurgical Wound | Surgical Wound Infection | Surgical Site Infection | Surgical Incision | Amputation Stump; Infection